The International Myeloma Working Group has suggested a minimum target of 4 × 10^6 CD34 +/kg and, if feasible, an average of 8 − 10 × 10^6 CD34 +/kg should be collected, allowing most myeloma patients to undergo two autografts during the course of their disease [8]. This evidence concerns the gene CD34 and plasma cell myeloma.